Skip to main content
. 2023 Mar 6;12(9):10294–10302. doi: 10.1002/cam4.5758

FIGURE 1.

FIGURE 1

The flowchart to select eligible recurrence HCC patients and the analysis process for the study. A group, rHCC patients whose recurrence time is shorter than cutoff time; B group, rHCC patients whose recurrence time is longer than cutoff time. Abbreviations: LR, liver resection; MVI, microvascular invasion; OS, overall survival; rHCC, recurrence hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.